Literature DB >> 22116632

Non-receptor tyrosine kinase 2 reaches its lowest expression levels in human breast cancer during regional nodal metastasis.

Qing-Xiang Amy Sang1, Yan-Gao Man, You Me Sung, Zahraa I Khamis, Lihua Zhang, Mi-Hye Lee, Stephen W Byers, Ziad J Sahab.   

Abstract

Almost half of breast Ductal Carcinoma in situ are likely to remain non threatening in situ lesions with no invasion to the surrounding stroma and no metastases. The majority of focal disruptions in myoepithelial (ME) cell layers indicative of invasion onset were found to be overlying epithelial cell clusters with no or substantially reduced estrogen receptor α (ERα) expression. Here we report the down-regulation of tyrosine kinase-2 (TYK2) and up-regulation of strumpellin expression, among other proteins in ERα(-) cells located at disrupted ME layers compared to adjacent ERα(+) cells overlying an intact myoepithelial layer. ERα(+) and ERα(-) cells were microdissected from the same in vivo human breast cancer tissues, proteins were extracted and separated utilizing Differential in-Gel Electrophoresis followed by trypsin digestion, MALDI-TOF analysis, and protein identification. Proteins expressed by ERα(-) cell clusters were found to express higher levels of strumpellin that binds to valosin-containing protein (VCP) to slow-down wound closure and promote growth; and lower levels of TYK2, a jak protein necessary for lineage specific differentiation. TYK2 levels were further analyzed by immunohistochemistry in a cohort composed of 70 patients with broad clinical characteristics. TYK2 levels were minimal in TxN1M0 breast cancers which is the stage where the initial regional lymph node metastasis is observed. Our data highlight the role of TYK2 downregulation in breast cancer cell de-differentitation and initiation of regional metastasis. In addition, the aggressiveness of the ERα(-) cell clusters compared to ERα(+) ones present in the same duct of the same patient was confirmed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22116632      PMCID: PMC3449303          DOI: 10.1007/s10585-011-9437-1

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  29 in total

1.  tyk2, prototype of a novel class of non-receptor tyrosine kinase genes.

Authors:  I Firmbach-Kraft; M Byers; T Shows; R Dalla-Favera; J J Krolewski
Journal:  Oncogene       Date:  1990-09       Impact factor: 9.867

2.  Commentary on H. Ide et al., "Tyk2 expression and its signaling enhances the invasiveness of prostate cancer cells".

Authors:  Christian Schuster; Mathias Müller; Michael Freissmuth; Veronika Sexl; Dagmar Stoiber
Journal:  Biochem Biophys Res Commun       Date:  2007-12-17       Impact factor: 3.575

3.  Atypical E-cadherin expression in cell clusters overlying focally disrupted mammary myoepithelial cell layers: implications for tumor cell motility and invasion.

Authors:  Xichen Zhang; Shahreyar Shar Hashemi; Morvarid Yousefi; Chunling Gao; Joy Sheng; Jinsong Ni; Wan Wang; Jeffrey Mason; Yan-Gao Man
Journal:  Pathol Res Pract       Date:  2009-04-22       Impact factor: 3.250

4.  Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction.

Authors:  A F Wilks
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

Review 5.  The significance of focal myoepithelial cell layer disruptions in human breast tumor invasion: a paradigm shift from the "protease-centered" hypothesis.

Authors:  Yan-Gao Man; Qing-Xiang Amy Sang
Journal:  Exp Cell Res       Date:  2004-12-10       Impact factor: 3.905

6.  Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity.

Authors:  Yoshiyuki Minegishi; Masako Saito; Tomohiro Morio; Ken Watanabe; Kazunaga Agematsu; Shigeru Tsuchiya; Hidetoshi Takada; Toshiro Hara; Nobuaki Kawamura; Tadashi Ariga; Hideo Kaneko; Naomi Kondo; Ikuya Tsuge; Akihiro Yachie; Yukio Sakiyama; Tsutomu Iwata; Fumio Bessho; Tsutomu Ohishi; Kosuke Joh; Kohsuke Imai; Kazuhiro Kogawa; Miwa Shinohara; Mikiya Fujieda; Hiroshi Wakiguchi; Srdjan Pasic; Mario Abinun; Hans D Ochs; Eleonore D Renner; Annette Jansson; Bernd H Belohradsky; Ayse Metin; Norio Shimizu; Shuki Mizutani; Toshio Miyawaki; Shigeaki Nonoyama; Hajime Karasuyama
Journal:  Immunity       Date:  2006-11       Impact factor: 31.745

7.  TYK2 is a key regulator of the surveillance of B lymphoid tumors.

Authors:  Dagmar Stoiber; Boris Kovacic; Christian Schuster; Carola Schellack; Marina Karaghiosoff; Rita Kreibich; Eva Weisz; Michaela Artwohl; Olaf C Kleine; Mathias Muller; Sabina Baumgartner-Parzer; Jacques Ghysdael; Michael Freissmuth; Veronika Sexl
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

8.  CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: II. Analysis of activating signal transduction pathways, transcriptional, post-transcriptional, and post-translational control.

Authors:  G S Sivko; D C Sanford; L D Dearth; D Tang; J W DeWille
Journal:  J Cell Biochem       Date:  2004-11-01       Impact factor: 4.429

9.  Anion exchange fractionation of serum proteins versus albumin elimination.

Authors:  Ziad J Sahab; Kenneth A Iczkowski; Qing-Xiang Amy Sang
Journal:  Anal Biochem       Date:  2007-06-08       Impact factor: 3.365

Review 10.  Cytokine receptor signalling.

Authors:  J N Ihle
Journal:  Nature       Date:  1995-10-19       Impact factor: 49.962

View more
  5 in total

1.  Analysis of tubulin alpha-1A/1B C-terminal tail post-translational poly-glutamylation reveals novel modification sites.

Authors:  Ziad J Sahab; Alexander Kirilyuk; Lihua Zhang; Zahraa I Khamis; Petr Pompach; Youme Sung; Stephen W Byers
Journal:  J Proteome Res       Date:  2012-02-15       Impact factor: 4.466

2.  Identification of estrogen receptor proteins in breast cancer cells using matrix-assisted laser desorption/ionization time of flight mass spectrometry (Review).

Authors:  Zbynek Heger; Miguel Angel Merlos Rodrigo; Sona Krizkova; Ondrej Zitka; Miroslava Beklova; Rene Kizek; Vojtech Adam
Journal:  Oncol Lett       Date:  2014-02-26       Impact factor: 2.967

Review 3.  TYK2: An Upstream Kinase of STATs in Cancer.

Authors:  Katharina Wöss; Natalija Simonović; Birgit Strobl; Sabine Macho-Maschler; Mathias Müller
Journal:  Cancers (Basel)       Date:  2019-11-05       Impact factor: 6.639

4.  Identification of Prognostic Biomarkers and Molecular Targets Among JAK Family in Breast Cancer.

Authors:  Fangteng Liu; Hengyu Wu
Journal:  J Inflamm Res       Date:  2021-01-14

5.  Establishing the role of tyrosine kinase 2 in cancer.

Authors:  Caroline Ubel; Stephanie Mousset; Denis Trufa; Horia Sirbu; Susetta Finotto
Journal:  Oncoimmunology       Date:  2013-01-01       Impact factor: 8.110

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.